Sun Pharma's acquisition of Organon open for views in EU
MLex Summary: Parties interested in plans by India-based specialty generics business Sun Pharma to buy US healthcare business Organon have ten days to provide comments to the European Commission. The EU...To view the full article, register now.
Already a subscriber? Click here to view full article